Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Dec 30, 2019 7:45pm
183 Views
Post# 30503353

RE:RE:This the NEW leadership at TLT

RE:RE:This the NEW leadership at TLT
skier59 wrote: He is a Winner, and exactly what we needed to lead us forward. Lucky to have him join the TurtleTeam :).......maybe they will evolve into the RabbitTeam...????


winr88 wrote: No where to go but UP

Dr. Shawn Shirazi Ph.D., is Chief Executive Officer at Theralase Technologies Inc. since October 31, 2019 and served as its Chief Executive Officer of Drug since February 25, 2019 until October 31, 2019. Dr. Shirazi served as Senior Director of Global Pre-Commercial Quality and Technical Affairs of Perrigo Company plc since August, 2007. Dr. Shirazi was responsible for partnering with Perrigo Global Scientific Affairs to manage the manufacture and release of clinical-trial materials supporting submissions to regulatory authorities and product commercialization. Dr. Shirazi has experience in: pharmaceutical drug formulation and development, clinical trial management, Good Manufacturing Practices (“GMP”) international drug manufacture, international regulatory guidelines and quality assurance in GMP drug manufacture. He has held senior roles with both start-ups and large pharmaceutical organizations, including: Executive Director and Vice President of Research and Development for Torpharm Inc (Division of Apotex (Apotex worldwide revenue $CAN 1.19 B (2016), Senior Director Global Research and Development of Perrigo Company (NYSE: PRGO, $US 6.7 B Market Cap) and Chief Operating Officer – North America for Daxinganling Lingonberry Boreal Biotech Co. Ltd. (Leading manufacturer of high quality plant extracts, based in China), During his career, Dr. Shirazi has led the generic drug development programs for numerous pharmaceutical organizations, resulting in multiple “First To File” (“FTF”) drug applications, allowing product exclusivity, as well as global leadership of research and development and merger and acquisition portfolios. He holds a Bachelor's degree in Chemistry from York University and a PhD in Pharmacology from the University of Ottawa.





The most important thing is how to curb Rogers Dumbling White from doing idiot style dilutions again and again, we can totaly rely on science side itself even the stupid management dosen't do anything.
Bullboard Posts